Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic

Mrinal M. Patnaik; Terra Lasho; Eric Padron; Kristen McCullough; Aref Al-kali; Ayalew Tefferi; Amer M. Zeidan; Naseema Gangat; Michael Savona; David P. Steensma; Eric Solary

doi:10.1002/ajh.25853

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic

Mrinal M. Patnaik, Terra Lasho, Eric Padron, Kristen McCullough, Aref Al-kali, Ayalew Tefferi, Amer M. Zeidan, Naseema Gangat, Michael Savona, David P. Steensma, Eric Solary

Hematology

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	E203-E208
Journal	American journal of hematology
Volume	95
Issue number	8
DOIs	https://doi.org/10.1002/ajh.25853
State	Published - Aug 1 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25853

Cite this

Patnaik, M. M., Lasho, T., Padron, E., McCullough, K., Al-kali, A., Tefferi, A., Zeidan, A. M., Gangat, N., Savona, M., Steensma, D. P., & Solary, E. (2020). Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic. American journal of hematology, 95(8), E203-E208. https://doi.org/10.1002/ajh.25853

Patnaik, MM, Lasho, T, Padron, E, McCullough, K, Al-kali, A, Tefferi, A, Zeidan, AM, Gangat, N, Savona, M, Steensma, DP & Solary, E 2020, 'Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic', American journal of hematology, vol. 95, no. 8, pp. E203-E208. https://doi.org/10.1002/ajh.25853

@article{d05eb9488fed49cda3b82e95693ff9d9,

title = "Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic",

author = "Patnaik, {Mrinal M.} and Terra Lasho and Eric Padron and Kristen McCullough and Aref Al-kali and Ayalew Tefferi and Zeidan, {Amer M.} and Naseema Gangat and Michael Savona and Steensma, {David P.} and Eric Solary",

note = "Funding Information: Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA”. A.Z. is a Leukemia and Lymphoma Society Scholar in Clinical Research and is also supported by a NCI{\textquoteright}s Cancer Clinical Investigator Team Leadership Award (CCITLA). Research reported in this publication was in part supported by the National Cancer Institute of the National Institutes of Health under Award Number P30 CA016359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M.S. is a Leukemia and Lymphoma Society Scholar in Clinical Research. David Steensma is supported by the Edward P. Evans Foundation.",

year = "2020",

month = aug,

day = "1",

doi = "10.1002/ajh.25853",

language = "English (US)",

volume = "95",

pages = "E203--E208",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "8",

}

TY - JOUR

T1 - Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic

AU - Patnaik, Mrinal M.

AU - Lasho, Terra

AU - Padron, Eric

AU - McCullough, Kristen

AU - Al-kali, Aref

AU - Tefferi, Ayalew

AU - Zeidan, Amer M.

AU - Gangat, Naseema

AU - Savona, Michael

AU - Steensma, David P.

AU - Solary, Eric

N1 - Funding Information: Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA”. A.Z. is a Leukemia and Lymphoma Society Scholar in Clinical Research and is also supported by a NCI’s Cancer Clinical Investigator Team Leadership Award (CCITLA). Research reported in this publication was in part supported by the National Cancer Institute of the National Institutes of Health under Award Number P30 CA016359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M.S. is a Leukemia and Lymphoma Society Scholar in Clinical Research. David Steensma is supported by the Edward P. Evans Foundation.

PY - 2020/8/1

Y1 - 2020/8/1

UR - http://www.scopus.com/inward/record.url?scp=85084489814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084489814&partnerID=8YFLogxK

U2 - 10.1002/ajh.25853

DO - 10.1002/ajh.25853

M3 - Letter

C2 - 32356322

AN - SCOPUS:85084489814

SN - 0361-8609

VL - 95

SP - E203-E208

JO - American journal of hematology

JF - American journal of hematology

IS - 8

ER -

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this